Concentrix (NASDAQ:CNXC) Issues Q3 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) updated its third quarter 2026 earnings guidance on Monday morning. The company provided earnings per share guidance of 2.650-2.770 for the period, compared to the consensus earnings per share estimate of 3.040. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 10.830-11.180 EPS.

Concentrix Trading Down 11.2%

CNXC opened at $22.41 on Wednesday. The stock has a market capitalization of $1.37 billion, a P/E ratio of -1.05, a P/E/G ratio of 0.32 and a beta of 0.44. Concentrix has a 12 month low of $19.12 and a 12 month high of $62.14. The firm’s fifty day simple moving average is $25.69 and its 200 day simple moving average is $31.96. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.43.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a positive return on equity of 18.93% and a negative net margin of 13.16%.Concentrix’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period in the previous year, the company posted $2.70 earnings per share. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, research analysts anticipate that Concentrix will post 10.42 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date is Friday, July 24th. Concentrix’s dividend payout ratio is currently -6.68%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CNXC. Barrington Research lowered their target price on Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday. Canaccord Genuity Group decreased their price objective on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a report on Tuesday. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Robert W. Baird decreased their price target on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday. Finally, Wall Street Zen cut shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $32.75.

Insider Activity at Concentrix

In related news, CFO Andre S. Valentine acquired 2,500 shares of the stock in a transaction dated Thursday, April 9th. The stock was bought at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the transaction, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at $2,489,394.70. The trade was a 2.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider directly owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.90% of the company’s stock.

Concentrix News Roundup

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix reported record second-quarter cash flow from operations of $258 million and adjusted free cash flow of $242 million, and management said iX Suite deals rose 400% year over year, signaling progress in its AI and software-related growth efforts.
• Positive Sentiment: Several analysts still see upside despite trimming targets: Barrington Research and Robert W. Baird both reiterated outperform ratings while cutting price targets to $30, and Canaccord Genuity kept a bullish stance even after lowering its forecast.
• Neutral Sentiment: The company declared a quarterly dividend of $0.36 per share, which implies a 5.7% annualized yield and may help support investor interest.
• Negative Sentiment: Q2 adjusted EPS of $2.63 missed the $2.64 consensus estimate, and revenue of $2.46 billion came in slightly below expectations, reinforcing concerns that growth is slowing.
• Negative Sentiment: Management also cut FY2026 and Q3 guidance below Wall Street forecasts, citing clients trimming spend; that downgrade to the outlook is the main reason the stock is under pressure.
• Negative Sentiment: Analysts and market commentary pointed to margin pressure, weaker cash generation in some measures, and leverage concerns, which are adding to the selloff in CNXC shares.

Institutional Investors Weigh In On Concentrix

Several hedge funds and other institutional investors have recently bought and sold shares of CNXC. AQR Capital Management LLC raised its holdings in Concentrix by 1.8% during the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after buying an additional 75,352 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Concentrix by 28.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock valued at $103,588,000 after purchasing an additional 551,778 shares during the last quarter. State Street Corp increased its holdings in Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock worth $85,776,000 after purchasing an additional 130,529 shares in the last quarter. First Trust Advisors LP grew its holdings in Concentrix by 37.7% during the fourth quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock worth $33,509,000 after buying an additional 220,590 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in Concentrix by 157.1% in the 4th quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after buying an additional 433,731 shares during the last quarter. 90.34% of the stock is owned by institutional investors.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.